First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 294.01 USD 3% Market Closed
Updated: May 15, 2024

Gross Margin
Bio Rad Laboratories Inc

53.5%
Current
56%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.5%
=
Gross Profit
1.4B
/
Revenue
2.6B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
US
Bio Rad Laboratories Inc
NYSE:BIO
8.4B USD
54%
US
Thermo Fisher Scientific Inc
NYSE:TMO
230B USD
40%
US
Danaher Corp
NYSE:DHR
192B USD
58%
US
Agilent Technologies Inc
NYSE:A
44.3B USD
51%
US
IQVIA Holdings Inc
NYSE:IQV
42B USD
35%
KR
Samsung Biologics Co Ltd
KRX:207940
55.6T KRW
49%
CH
Lonza Group AG
SIX:LONN
37.9B CHF
36%
US
Mettler-Toledo International Inc
NYSE:MTD
32B USD
59%
IE
ICON PLC
NASDAQ:ICLR
26.1B USD
30%
US
West Pharmaceutical Services Inc
NYSE:WST
25.9B USD
37%
US
Waters Corp
NYSE:WAT
21.3B USD
60%
Bio Rad Laboratories Inc
NYSE:BIO
Country US
Market Cap 8.4B USD
Gross Margin
54%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 230B USD
Gross Margin
40%
Danaher Corp
NYSE:DHR
Country US
Market Cap 192B USD
Gross Margin
58%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 44.3B USD
Gross Margin
51%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 42B USD
Gross Margin
35%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.6T KRW
Gross Margin
49%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 37.9B CHF
Gross Margin
36%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 32B USD
Gross Margin
59%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 26.1B USD
Gross Margin
30%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 25.9B USD
Gross Margin
37%
Waters Corp
NYSE:WAT
Country US
Market Cap 21.3B USD
Gross Margin
60%

Profitability Report

View the profitability report to see the full profitability analysis for Bio Rad Laboratories Inc.

Full Profitability Report

See Also

Summary
BIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIO stock valuation using valuation multiples.
Wall Street Estimates
BIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.5%
=
Gross Profit
1.4B
/
Revenue
2.6B
What is the Gross Margin of Bio Rad Laboratories Inc?

Based on Bio Rad Laboratories Inc's most recent financial statements, the company has Gross Margin of 53.5%.

ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.